An Analogue of the Antibiotic Teicoplanin Prevents Flavivirus Entry In Vitro

• Tine De Burghgraeve,

  Affiliation Rega Institute for Medical Research, K.U. Leuven, Leuven, Belgium

  ⨯
• Suzanne J. F. Kaptein,

  Affiliation Rega Institute for Medical Research, K.U. Leuven, Leuven, Belgium

  ⨯
• Nilda V. Ayala-Nunez,

  Affiliation University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

  ⨯
• Juan A. Mondotte,

  Affiliation Fundacion Instituto Leloir, Conicet, Buenos Aires, Argentina

  ⨯
• Boris Pastorino,

  Affiliation UMR190 ‘Emergence des Pathologies Virales’, Université de la Méditerranée, Marseille, France

  ⨯
• Svetlana S. Printsevskaya,

  Affiliation Gause Institute of New Antibiotics, Russian Academy of Medical Sciences, Moscow, Russia

  ⨯
• Xavier de Lamballerie,

  Affiliation UMR190 ‘Emergence des Pathologies Virales’, Université de la Méditerranée, Marseille, France

  ⨯
• Michael Jacobs,

  Affiliation Department of Medicine, Royal Free & University College Medical School, London, United Kingdom

  ⨯
• Maria Preobrazhenskaya,

  Affiliation Gause Institute of New Antibiotics, Russian Academy of Medical Sciences, Moscow, Russia

  ⨯
• Andrea V. Gamarnik,

  Affiliation Fundacion Instituto Leloir, Conicet, Buenos Aires, Argentina

  ⨯
• Jolanda M. Smit,

  Affiliation University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

  ⨯
• Johan Neyts

  * E-mail: Johan.Neyts@rega.kuleuven.be

  Affiliation Rega Institute for Medical Research, K.U. Leuven, Leuven, Belgium

  ⨯